Sunday, July 26, 2026

Knowledge Files How We Source Search

#Biotech M&A

2 articles

Gilead-Backed Lakefront Closes Ouro Deal with $500M Reserved for Further Immunology Buys

Healthcare Sector

Gilead-Backed Lakefront Closes Ouro Deal with $500M Reserved for Further Immunology Buys

Salvado•Jun 13, 2026

Gilead Closes Ouro Deal; Lakefront Gets $500M War Chest as Nanobiotix Posts 57% NSCLC Response Rate

Pharma & Biotech Equities

Gilead Closes Ouro Deal; Lakefront Gets $500M War Chest as Nanobiotix Posts 57% NSCLC Response Rate

Salvado•Jun 11, 2026